Friday 20 July 2018

Novo Nordisk appoints new Egypt GM

CAIRO, September 28, 2017

Novo Nordisk, a leading global health care company, has appointed Hassan Fahmi as the new general manager for the company’s operations in Egypt.

Fahmi has more than 20 years of experience across business development, marketing and communications with proven leadership abilities among leading FMCG corporations and start-ups.

He had also held several managerial positions at Novo Nordisk prior to his latest appointment including business development manager, and marketing and Mapa director, where he was responsible for the entire diabetes and bio-pharm portfolios, achieving both market share growth and increased sales.

Fahmi has a proven track record of brand-building and leadership, coupled with diverse experience of nearly 24 years in Egypt and the Gulf region that were key to his appointment as general manager and ability to lead the company’s operations successfully in Egypt.

On the new role, Fahmi said: "Egypt is a hub for Novo Nordisk’s operations in the Middle East and Africa and I’m honored to lead the company's operations in Egypt, cooperating with more than 160 employees in the local market and putting Egyptian patients at the top of our priorities."

Headquartered in Denmark, Novo Nordisk employs approximately 41,400 people in 77 countries and markets its products in more than 165 countries.

As a part of its commitment to Egyptian patients, Novo Nordisk has launched numerous initiatives in recent years including the opening of Novo care centers across 16 governorates to raise diabetes awareness among people with the disease and the community.

"In the coming period, we aim to achieve more growth and expansion in Egypt through initiatives and activities that aim to best serve Egyptian patients, all in cooperation with Ministry of Health and its affiliates," he added.-TradeArabia News Service

Tags: Novo Nordisk |

calendarCalendar of Events